Braslyn
Latest statistics and disclosures from Braslyn's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Inseego, TNGX, and represent 100.00% of Braslyn's stock portfolio.
- Reduced shares in these 2 stocks: Mirati Therapeutics (-$184M), Inseego (-$19M).
- Sold out of its position in Mirati Therapeutics.
- Braslyn was a net seller of stock by $-203M.
- Braslyn has $2.3M in assets under management (AUM), dropping by -98.74%.
- Central Index Key (CIK): 0001642355
Tip: Access up to 7 years of quarterly data
Positions held by Braslyn consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Braslyn
Braslyn holds 2 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Inseego Corp Common | 90.9 | $2.1M | -90% | 762k | 2.80 |
|
| Tango Therapeutics Common (TNGX) | 9.1 | $214k | 27k | 7.94 |
|
Past Filings by Braslyn
SEC 13F filings are viewable for Braslyn going back to 2023
- Braslyn 2024 Q1 filed May 15, 2024
- Braslyn 2023 Q4 filed Feb. 14, 2024